Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage

NCT: NCT02792010 · COMPLETED

NCT IDNCT02792010
StatusCOMPLETED
Start Date2015-05
Completion2016-01

Brief Summary

Hip osteoarthritis is a frequent and invalidating disease. Early detection of cartilage modifications could provide better patient treatment. The T1rho MRI sequence allows the quantification of the cartilage signal that is correlated to modifications of the cartilage matrix, notably of the proteoglycans. The primary objective is to evaluate normal values of hip cartilage in vivo using T1rho MRI in healthy subjects and the reproducibility of the measurements. T1rho and T2 mapping sequences were acquired twice during the same session with 30 minutes interval to see if values were modified after a 30 minutes delay in a supine position. The secondary objective was to assess the correlation between T1rho and T2 values.

Frequently Asked Questions

What is Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage?

Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage is a clinical trial registered under NCT02792010. Current status: COMPLETED.

What is the status of NCT02792010?

The current status of NCT02792010 (Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage) is: COMPLETED.

When did Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage start?

Feasibility and Reproducibility of T1 Rho MRI in the Evaluation of Hip Cartilage started on 2015-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.